Sangamo Therapeutics(SGMO)

Search documents
Sangamo Therapeutics(SGMO) - 2020 Q4 - Annual Report
2021-02-23 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________________________________ Form 10-K _______________________________________________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the trans ...
Sangamo Therapeutics (SGMO) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow
2021-01-19 21:54
| --- | --- | |-----------------------------------|-------| | | | | | | | | | | Corporate Presentation | | | | | | | | | J.P. Morgan Healthcare Conference | | | Sandy Macrae, CEO | | | January 13, 2021 | | Forward-Looking Statements This presentation contains forward-looking statements regarding our current expectations. These forward-looking statements include, without limitation, statements relating to the potential to develop, obtain regulatory approvals for and commercialize safe and effective therapies ...